The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing.
ATL
HBZ
HTLV-1
alternative splicing
interactome
protein network
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
05
2022
accepted:
07
07
2022
entrez:
18
8
2022
pubmed:
19
8
2022
medline:
20
8
2022
Statut:
epublish
Résumé
Adult T-cell leukemia/lymphoma (ATL) is a T-cell lymphoproliferative neoplasm caused by the human T-cell leukemia virus type 1 (HTLV-1). Two viral proteins, Tax-1 and HBZ play important roles in HTLV-1 infectivity and in HTLV-1-associated pathologies by altering key pathways of cell homeostasis. However, the molecular mechanisms through which the two viral proteins, particularly HBZ, induce and/or sustain the oncogenic process are still largely elusive. Previous results suggested that HBZ interaction with nuclear factors may alter cell cycle and cell proliferation. To have a more complete picture of the HBZ interactions, we investigated in detail the endogenous HBZ interactome in leukemic cells by immunoprecipitating the HBZ-interacting complexes of ATL-2 leukemic cells, followed by tandem mass spectrometry analyses. RNA seq analysis was performed to decipher the differential gene expression and splicing modifications related to HTLV-1. Here we compared ATL-2 with MOLT-4, a non HTLV-1 derived leukemic T cell line and further compared with HBZ-induced modifications in an isogenic system composed by Jurkat T cells and stably HBZ transfected Jurkat derivatives. The endogenous HBZ interactome of ATL-2 cells identified 249 interactors covering three main clusters corresponding to protein families mainly involved in mRNA splicing, nonsense-mediated RNA decay (NMD) and JAK-STAT signaling pathway. Here we analyzed in detail the cluster involved in RNA splicing. RNAseq analysis showed that HBZ specifically altered the transcription of many genes, including crucial oncogenes, by affecting different splicing events. Consistently, the two RNA helicases, members of the RNA splicing family, DDX5 and its paralog DDX17, recently shown to be involved in alternative splicing of cellular genes after NF-κB activation by HTLV-1 Tax-1, interacted and partially co-localized with HBZ. For the first time, a complete picture of the endogenous HBZ interactome was elucidated. The wide interaction of HBZ with molecules involved in RNA splicing and the subsequent transcriptome alteration strongly suggests an unprecedented complex role of the viral oncogene in the establishment of the leukemic state.
Identifiants
pubmed: 35979358
doi: 10.3389/fimmu.2022.939863
pmc: PMC9376625
doi:
Substances chimiques
Basic-Leucine Zipper Transcription Factors
0
HBZ protein, human T-cell leukemia virus type I
0
Retroviridae Proteins
0
Viral Proteins
0
Ddx5 protein, human
EC 3.6.1.-
DEAD-box RNA Helicases
EC 3.6.4.13
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
939863Informations de copyright
Copyright © 2022 Shallak, Alberio, Fasano, Monti, Iacobucci, Ladet, Mortreux, Accolla and Forlani.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Lancet. 1986 May 3;1(8488):1031-2
pubmed: 2871307
Jpn J Cancer Res. 1993 Dec;84(12):1265-7
pubmed: 8294217
Front Microbiol. 2019 Apr 26;10:819
pubmed: 31080441
Genome Biol. 2014;15(12):550
pubmed: 25516281
Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415-9
pubmed: 6261256
Retrovirology. 2008 Apr 22;5:34
pubmed: 18426605
Emerg Microbes Infect. 2014 Sep;3(9):e63
pubmed: 26038756
Nat Commun. 2020 Jun 16;11(1):3045
pubmed: 32546717
Adv Ther. 2018 Feb;35(2):135-152
pubmed: 29411267
Retrovirology. 2015 Jul 04;12:59
pubmed: 26140924
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12813-8
pubmed: 16123126
Curr Opin Virol. 2013 Dec;3(6):684-91
pubmed: 24060211
Genes Dev. 2020 Mar 1;34(5-6):413-427
pubmed: 32001512
Nat Commun. 2016 Apr 12;7:11292
pubmed: 27068814
Science. 2007 Feb 16;315(5814):972-6
pubmed: 17218491
PLoS Negl Trop Dis. 2017 Jan 17;11(1):e0005285
pubmed: 28095504
Cells. 2021 Jan 26;10(2):
pubmed: 33530521
Haematologica. 2021 Aug 01;106(8):2076-2085
pubmed: 33626865
Blood. 1977 Sep;50(3):481-92
pubmed: 301762
Retrovirology. 2006 Mar 02;3:15
pubmed: 16512901
J Clin Invest. 2021 Dec 15;131(24):
pubmed: 34907908
Retrovirology. 2005 Oct 22;2:64
pubmed: 16242045
Int J Cancer. 2004 Apr 20;109(4):559-67
pubmed: 14991578
Nat Rev Cancer. 2007 Apr;7(4):270-80
pubmed: 17384582
Curr Protoc Bioinformatics. 2014 Sep 08;47:8.13.1-24
pubmed: 25199793
Lancet. 1985 Aug 24;2(8452):407-10
pubmed: 2863442
Genome Res. 2017 Jun;27(6):1087-1097
pubmed: 28420690
Int J Mol Sci. 2021 Jul 27;22(15):
pubmed: 34360767
Retrovirology. 2014 Dec 18;11:119
pubmed: 25519886
Sci Rep. 2018 Mar 9;8(1):4307
pubmed: 29523794
Front Microbiol. 2017 Aug 02;8:1425
pubmed: 28824561
J Exp Med. 1985 Dec 1;162(6):2169-74
pubmed: 2866223
Cell Res. 2009 Dec;19(12):1388-400
pubmed: 19786986
Nat Rev Mol Cell Biol. 2016 Jul;17(7):426-38
pubmed: 27251421
Genome Biol. 2019 Nov 29;20(1):259
pubmed: 31783898
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1269-E1278
pubmed: 29358408
Hum Mol Genet. 2021 Jun 17;30(13):1175-1187
pubmed: 33601422
PLoS One. 2020 Sep 4;15(9):e0238037
pubmed: 32886703
Sci Rep. 2017 Oct 9;7(1):12849
pubmed: 28993637
Retrovirology. 2019 Dec 16;16(1):39
pubmed: 31842895
Oncogene. 2005 Sep 5;24(39):5976-85
pubmed: 16155604
Front Microbiol. 2020 Mar 06;11:356
pubmed: 32210945
Nat Genet. 2015 Nov;47(11):1304-15
pubmed: 26437031
Eur J Haematol. 2020 Oct;105(4):460-467
pubmed: 32574386
PLoS Pathog. 2021 Sep 20;17(9):e1009919
pubmed: 34543356
Retrovirology. 2020 Jan 8;17(1):2
pubmed: 31915026
J Virol. 2007 Feb;81(4):1543-53
pubmed: 17151132